Date: 02-Aug-2019

MediBeacon enters into $30 M partnership with Huadong Medicine

US based MediBeacon Inc., whose largest shareholder is Pansend Life Sciences, LLC, a subsidiary of HC2 Holdings, Inc., has announced that they have entered into a definitive agreement with Huadong Medicine, a publicly traded company on the Shenzhen Stock Exchange.